General Catalyst Group Management’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

General Catalyst Group Management’s Portfolio REVH Stock Details REVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,223,750	Closed	-$12M	–	14
2022 Q3	$12M	Buy	1,223,750 +53,125	+5%	+$521K	1.11%	13
2022 Q2	$11.5M	Hold	1,170,625	–	–	1.02%	13
2022 Q1	$11.6M	Hold	1,170,625	–	–	0.66%	14
2021 Q4	$11.6M	Hold	1,170,625	–	–	0.44%	13
2021 Q3	$11.5M	Hold	1,170,625	–	–	0.59%	12
2021 Q2	$11.8M	Buy	+1,170,625	New	+$11.5M	0.51%	10

General Catalyst Group Management's REVH Position: Q4 2022 in Review

General Catalyst Group Management sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 1,223,750 shares — an estimated $12M sold.

General Catalyst Group Management first reported a position in REVH in Q2 2021 and held it in 6 quarters. The position peaked at $12M in Q3 2022. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

General Catalyst Group Management reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
General Catalyst Group Management sold 1,223,750 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $12M.
General Catalyst Group Management first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q2 2021 and held it in 6 quarters.
General Catalyst Group Management's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $12M in Q3 2022.
0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on General Catalyst Group Management's 13F filing for Q4 2022, filed 15 Feb 2023.